Prediction for recurrent non-muscle invasive bladder cancer

Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis

(2022) Joep J. de Jong et al.   BRITISH JOURNAL OF CANCER

Prediction of recurrence of non-muscle invasive bladder cancer: The role of androgen receptor and miRNA-2909

(2022) Hazim Hadi Muzaail et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Biomarkers for Precision Urothelial Carcinoma Diagnosis: Current Approaches and the Application of Single-Cell Technologies

(2021) Michelle Hong et al.   Cancers

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer

(2021) Sia Viborg Lindskrog et al.   Nature Communications

Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer

(2021) Huanjun Wang et al.   CLINICAL CANCER RESEARCH

Ultra-high-throughput single-cell RNA sequencing and perturbation screening with combinatorial fluidic indexing

(2021) Paul Datlinger et al.   NATURE METHODS

Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis

(2021) Hui Jiang et al.   PLoS One

Bladder Cancer (NMIBC) in a population-based cohort from Stockholm County with long-term follow-up; A comparative analysis of prediction models for recurrence and progression, including external validation of the updated 2021 E.A.U. model

(2021) Zachary Dovey et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Validation of EORTC, CUETO, and EAU risk stratification in prediction of recurrence, progression, and death of patients with initially non-muscle-invasive bladder cancer (NMIBC): A cohort analysis

(2020) Mateusz Jobczyk et al.   Cancer Medicine

Overview of multiplex immunohistochemistry/immunofluorescence techniques in the era of cancer immunotherapy

(2020) Wei Chang Colin Tan et al.   Cancer Communications

Utility of the EORTC risk tables and CUETO scoring model for predicting recurrence and progression in non-muscle-invasive bladder cancer patients treated with routine second transurethral resection

(2019) Guoxian Zhang et al.   WORLD JOURNAL OF UROLOGY

MicroRNA Dysregulation and Non-Muscle–Invasive Bladder Cancer Prognosis

(2019) Angeline S. Andrew et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Liquid Biopsy: General Concepts

(2019) Geoffroy Poulet et al.   ACTA CYTOLOGICA

Reassessment of Exosome Composition

(2019) Dennis K. Jeppesen et al.   CELL

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

(2019) Qianwei Ye et al.   Molecular Cancer

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update

(2019) Marko Babjuk et al.   EUROPEAN UROLOGY

Mechanisms of nuclear content loading to exosomes

(2019) Akira Yokoi et al.   Science Advances

Progressive tissue biomarker profiling in non-muscle-invasive bladder cancer

(2018) David D’Andrea et al.   Expert Review of Anticancer Therapy

Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication

(2018) Mathilde Mathieu et al.   NATURE CELL BIOLOGY

Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer

(2017) Emil Christensen et al.   EUROPEAN UROLOGY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

(2017) Marko Babjuk et al.   EUROPEAN UROLOGY

Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy

(2017) Kim E.M. van Kessel et al.   JOURNAL OF UROLOGY

Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in a United States Population

(2017) Kourosh Ravvaz et al.   JOURNAL OF UROLOGY

Comparative Analysis of Single-Cell RNA Sequencing Methods

(2017) Christoph Ziegenhain et al.   MOLECULAR CELL

Cancer stem cells revisited

(2017) Eduard Batlle et al.   NATURE MEDICINE

Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma

(2017) Yair Lotan et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer

(2017) Lutao Du et al.   Oncotarget

Bladder cancer

(2017) Oner Sanli et al.   Nature Reviews Disease Primers

Economic Burden of Bladder Cancer Across the European Union

(2016) Jose Leal et al.   EUROPEAN UROLOGY

CUA guidelines on the management of non-muscle invasive bladder cancer

(2015) Wassim Kassouf et al.   CUAJ-Canadian Urological Association Journal

A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma

(2015) Thomas Seisen et al.   EUROPEAN UROLOGY

Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma

(2015) Kristian Krpina et al.   VIRCHOWS ARCHIV

Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer

(2015) Xin Zhang et al.   Oncotarget

Do Circulating Tumor Cells Have a Role in Deciding on Adjuvant Chemotherapy After Radical Cystectomy?

(2015) Armin Soave et al.   Current Urology Reports

Urinary Protein Biomarker Panel for the Detection of Recurrent Bladder Cancer

(2014) C. J. Rosser et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The prognostic value of P-cadherin in non-muscle-invasive bladder cancer

(2014) P. Wang et al.   EJSO

Circulating tumor cells in early bladder cancer: insight into micrometastatic disease

(2014) Cristina Raimondi et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Prospective External Validation of a Bladder Cancer Detection Model

(2014) Yair Lotan et al.   JOURNAL OF UROLOGY

The Health Economics of Bladder Cancer: An Updated Review of the Published Literature

(2014) Christina Yeung et al.   PHARMACOECONOMICS

Risk Prediction Scores for Recurrence and Progression of Non-Muscle Invasive Bladder Cancer: An International Validation in Primary Tumours

(2014) Moniek M. Vedder et al.   PLoS One

Fourth-generation sequencing in the cell and the clinic

(2014) Marco Mignardi et al.   Genome Medicine

Accuracy of the EORTC risk tables and of the CUETO scoring model to predict outcomes in non-muscle-invasive urothelial carcinoma of the bladder

(2013) E Xylinas et al.   BRITISH JOURNAL OF CANCER

Circulating Tumor Cells

(2013) V. Plaks et al.   SCIENCE

Ki-67 is an independent indicator in non–muscle invasive bladder cancer (NMIBC); Combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC

(2013) Weihong Ding et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Predicting Recurrence and Progression in Chinese Patients With Nonmuscle-invasive Bladder Cancer Using EORTC and CUETO Scoring Models

(2013) Tianyuan Xu et al.   UROLOGY

Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma

(2012) Tomislav Tadin et al.   Diagnostic Pathology

Prognostic Role and HER2 Expression of Circulating Tumor Cells in Peripheral Blood of Patients Prior to Radical Cystectomy: A Prospective Study

(2012) Michael Rink et al.   EUROPEAN UROLOGY

Cell-free microRNAs in urine as diagnostic and prognostic biomarkers of bladder cancer

(2012) SEOK JOONG YUN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

A Multigene Urine Test for the Detection and Stratification of Bladder Cancer in Patients Presenting with Hematuria

(2012) Paul O'Sullivan et al.   JOURNAL OF UROLOGY

Urine Markers for Detection and Surveillance of Non–Muscle-Invasive Bladder Cancer

(2011) Derya Tilki et al.   EUROPEAN UROLOGY

Optimization of Nonmuscle Invasive Bladder Cancer Recurrence Detection Using a Urine Based FGFR3 Mutation Assay

(2011) Tahlita C.M. Zuiverloon et al.   JOURNAL OF UROLOGY

Multicolor FISH (UroVysion) Facilitates Follow-up of Patients With High-Grade Urothelial Carcinoma of the Bladder

(2010) Hans-Martin Fritsche et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

(2010) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Tumor Self-Seeding: Bidirectional Flow of Tumor Cells

(2009) Cheuk T. Leung et al.   CELL

Tumor Self-Seeding by Circulating Cancer Cells

(2009) Mi-Young Kim et al.   CELL

Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical Cystectomy

(2009) Shahrokh F. Shariat et al.   JOURNAL OF UROLOGY

Cystoscopy Revisited as the Gold Standard for Detecting Bladder Cancer Recurrence: Diagnostic Review Bias in the Randomized, Prospective CEFUB Trial

(2009) Madelon N.M. van der Aa et al.   JOURNAL OF UROLOGY

Bladder Cancer Detection Using FISH (UroVysion Assay)

(2008) Kevin C. Halling et al.   ADVANCES IN ANATOMIC PATHOLOGY

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

(2007) Jesus Fernandez-Gomez et al.   EUROPEAN UROLOGY